An important goal in the treatment of insulin-dependent diabetes by pancreatic islet transplantation is the development of strategies that allow permanent survival of islet allografts without continuous host immunosuppression. In this study, we demonstrate that inoculation of allogeneic bone marrow into the thymus of adult rats treated with a single dose of anti-lymphocyte serum induces an unresponsive state that permits survival of subsequent pancreatic islet allografts transplanted to an extrathymic site. This effect is donor specific, cannot be reproduced by systemic administration of bone marrow, and is associated with persistence of chimeric cells in the thymus of the recipient. In addition, lymph node cells from long-term recipients of intrathymic bone marrow display markedly reduced proliferative responses to donor alloantigens in mixed lymphocyte culture. Interaction of maturing thymocytes with foreign alloantigens may produce the unresponsiveness. This model offers a potential approach for establishing donor-specific allograft acceptance in adult recipients. Diabetes 41:771-75, 1992 I nduction of donor-specific unresponsiveness represents the ideal approach for securing permanent survival of pancreatic islet allografts because it precludes rejection without the need for chronic immunosuppression of the host. Although it was demonstrated >30 yr ago that immunologic tolerance can be readily achieved in rodents by inoculation of donor-strain lymphohematopoietic cells at birth, tolerance induction in adult recipients has been more difficult, requiring extenFrom the Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
I nduction of donor-specific unresponsiveness represents the ideal approach for securing permanent survival of pancreatic islet allografts because it precludes rejection without the need for chronic immunosuppression of the host. Although it was demonstrated >30 yr ago that immunologic tolerance can be readily achieved in rodents by inoculation of donor-strain lymphohematopoietic cells at birth, tolerance induction in adult recipients has been more difficult, requiring exten-sive preparative conditioning by irradiation and/or treatment with nonspecific cytoablative chemotherapy (1) (2) (3) (4) . We previously reported that pancreatic islets implanted in the thymus of allogeneic adult rats survived permanently and, in addition, rendered the recipients tolerant of donor alloantigens (5) . In this study, the efficacy of this approach in promoting transplantation tolerance was assessed by examining the impact of intrathymic inoculation of allogeneic bone marrow cells (BMC) on the survival of extrathymic transplants of pancreatic islets. We demonstrate that rats pretreated with an intrathymic injection of allogeneic BMC are rendered specifically unresponsive to donor alloantigens and permanently accept subsequent donor-strain islet allografts. Furthermore, this result can be accomplished without need for other methods known to prolong islet allograft survival, such as pretransplant modulation of allograft immunogenicity or chronic immunosuppression of the recipient (6).
RESEARCH DESIGN AND METHODS Bone marrow inoculation and islet transplantation.
BMC were obtained from adult male Lewis (RT1 1 ) donors, depleted of contaminating erythrocytes by centrifugation on a Ficoll-isopaque gradient and inoculated intravenously into an abdominally displaced testicle or into both thymic lobes of histoincompatible male Wistar Furth (WF) (RT1") recipients. Each recipient received 60-70 x 10 6 nucleated cells; rats given intravenous BMC inocula received intrathymic injections of saline. Where noted, recipients were treated with a single dose of 1 cc rabbit anti-rat lymphocyte serum (ALS) i.p. (Accurate Chemical and Scientific, Westbury, NY) on the day of BMC injection. No additional immunosuppression was administered at any other time during the experiment. The rats were then rendered diabetic with 65 mg/kg streptozocin i.v. and received freshly isolated (uncultured) Lewis or DA (RT1 a ) islet allografts beneath the renal capsule 14 days after BMC inoculation. Only rats with nonfasting blood glucose levels >300 mg/dl were used as recipients. Islets were isolated as previously described (7) . Graft survival was monitored by daily blood glucose measurements, with rejection being defined as a return to hyperglycemia (blood glucose >200 mg/dl on 2 consecutive days). In recipients with persistent normoglycemia, islet allograft function was eventually confirmed by removal of the islet-bearing kidney for histological examination. Immunohistochemistry. To detect the presence of donor-strain cells in WF rats inoculated with Lewis BMC, acetone-fixed frozen sections (5-6 |xm) of thymus, peripheral lymph nodes, and testicle were incubated overnight at 4°C with culture supernatant containing a murine monoclonal antibody (1-1.69) specific for Lewis class I MHC antigens (RT1-A 1 ) (8). Sections were then exposed to biotinylated horse anti-mouse IgG followed by avidinconjugated peroxidase according to manufacturer's instructions (Vector Laboratories, Burlingame, CA). Conjugates were visualized with diaminobenzidine hydrochloride and lightly counterstained with methyl green before mounting. Control sections incubated without specific primary antibody did not show any background staining. H-thymidine (1 ixCi/well) on day 3 and harvested 24 h later. Statistics. Statistical differences between treatment groups were determined with Wilcoxon's rank-sum test. P < 0.05 was significant.
Mixed lymphocyte culture (MLC)
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RESULTS AND DISCUSSION
Normal WF recipients that were not pretreated with intrathymic Lewis BMC or ALS rapidly rejected the Lewis islet grafts (median survival time [MST] 9.5 days; Table  1 ). Five of six WF recipients that received intrathymic injections of saline in conjunction with ALS 2 wk before islet transplantation also promptly rejected Lewis islet allografts (MST 14.5 days), although one rat remained normoglycemic for >170 days. Intravenous injection of Lewis BMC in conjunction with ALS 2 wk before islet grafting led to modest prolongation of Lewis islet allograft survival (MST 22 days); however, all allografts eventually underwent rejection within 32 days. In contrast to all of these control groups, when Lewis BMC were administered intrathymically, five of seven WF recipients of Lewis islet allografts remained permanently normoglycemic. Histological examination of the grafts at the conclusion of the experimental period revealed numerous clusters of well-granulated islets with no evidence of intra-islet mononuclear cell infiltration (Fig. 1, A and B) . The specificity of the tolerant state induced by inoculation of Lewis BMC was assessed by grafting WF rats that had received intrathymic or intravenous Lewis BMC with pancreatic islets from DA (RT1 a ) donors. These third-party grafts were all rejected within 10 days (Table 2) .
Prolonged residence of allogeneic tissue in an immunologically privileged site weakens the host's immune responsiveness to subsequent donor-strain allografts transplanted to conventional sites (9, 10) . Because the thymic parenchyma is relatively inaccessible to the peripheral immune system (11), it was conceivable that the unresponsiveness observed in intrathymically treated rats was solely due to the presence of the conditioning BMC inoculum and that the special immunologic functions of the thymus were not relevant (i.e., its role in T-cell maturation and induction of self-tolerance) (12) . To evaluate this possibility, we implanted allogeneic Lewis BMC into another immunologically privileged site, the abdominally displaced testicle, of WF recipients given a single injection of ALS (9) . Two weeks after intratesticular BMC inoculation, these recipients were rendered diabetic and transplanted with Lewis islet allografts. All rats rapidly rejected the islets (MST 8 days), indicating that the protective influence of the intrathymic bone marrow inoculum on subsequent allografts was unlikely to be explained entirely by its inoculation in a privileged site (Table 1) .
In accordance with the in vivo findings, intrathymic inoculation of allogeneic Lewis BMC had a marked influence on T-cell-mediated responses to donor alloantigens in vitro. LN cells from recipients in which long-term Lewis islet allograft survival was achieved by intrathymic BMC inoculation responded normally to third-party DA stimulators in an MLC system; however, proliferation of these cells to Lewis stimulators was consistently decreased compared with responses of unmanipulated controls (Fig. 2) . Because proliferation of rat lymphocytes in primary MLC predominantly reflects activity of class II MHC-restricted CD4 + T cells (13, 14) , these results suggest that the tolerant state at least in part affects this cell population. Interestingly, we previously found that in WF rats bearing long-term intrathymic Lewis islets, MLC responses to Lewis alloantigens were not reduced compared with unmanipulated controls (5) . One explanation for this difference is that in contrast to bone marrow, which consists of 5-10% class II MHC + cells and con- Values in parentheses are median survival times. *Administered in conjunction with 1 cc anti-rat lymphocyte serum i.p. 14 days before islet transplantation.
tains progenitors capable of differentiating into populations that constitutively express high levels of class II MHC antigens (dendritic cells, macrophages, B cells), class II expression on islets is limited to rare intra-islet dendritic cells (15, 16) . Consequently, the residence of islets in the thymic microenvironment may not measurably affect class 11-restricted in vitro responses. In several models of specific unresponsiveness achieved by allogeneic BMC transplantation, tolerance correlates with the presence of microchimerism in the thymus and peripheral lymphoid organs of the recipients (17) (18) (19) . To determine whether a similar chimeric state had developed in our model, the lymphoid organs of WF rats that had received intrathymic Lewis BMC (without subsequent islet grafts) were examined at various times after inoculation by immunohistochemistry with a murine monoclonal antibody (1-1.69) specific for Lewis class I alloantigens (8) . Although chimerism was not observed in the LN of these rats at any time after intrathymic injection, donor-strain cells were uniformly detected in thymic sections from rats inoculated with Lewis BMC 2-45 days earlier. Similarly, in three of four rats that had accepted Lewis islet grafts after conditioning with intrathymic Lewis BMC, donor-strain cells were found in the thymus when it was examined 140-170 days after inoculation, although the number of cells was reduced compared to organs examined at earlier time points (Fig. 1, C-E) . In contrast, donor-strain cells were not detected in the thymus, LN, or testicles of rats given intravenous or intratesticular BMC. Thus, it appears that the thymic microenvironment can support the long-term survival of implanted hematopoietic cells and is capable of protecting them (or their descendants) from elimination by immune mechanisms. Our findings demonstrate that intrathymic inoculation of allogeneic BMC is an effective means by which specific unresponsiveness to pancreatic islet allografts can be achieved. Significantly, we show that this tolerant state develops relatively soon after thymic injection and, as demonstrated by the prompt rejection of grafts by rats given intravenous or intratesticular BMC, requires that the allogeneic inoculum is situated in the thymic microenvironment.
Several experimental systems have shown that intrathymic inoculation of foreign substances can have a profound impact on the systemic immune responsiveness of the recipient. Staples et al. (20) were the first to report that irradiated rats given intrathymic injections of bovine y-globulin displayed markedly reduced antibody synthesis and delayed-type hypersensitivity responses to the antigen (20) . More recently, it was demonstrated that intrathymic injection of allogeneic CD4~/CD8~ prothymocytes, B cells, or dendritic cells could specifically reduce T-cell-mediated responses to donor antigens, an effect attributed to intrathymic deletion or functional inactivation of donor-specific clones (21, 22) . A similar mechanism could be invoked to explain the tolerant state observed in this study. Intrathymic inoculation of allogeneic BMC may provide a particularly efficient means of establishing a state of chimerism in the thymus and promoting exposure of maturing thymocytes to donor alloantigens. The resulting interactions may then lead to selective deletion or functional inactivation of donorspecific clones before their migration to the periphery. Because the allogeneic inoculum is introduced at a time when the peripheral T-cell pool has been transiently depleted by ALS, this effect would be expected to have a maximal influence on the reconstituting T-cell repertoire. In addition, the relative immunologic privilege of the thymic parenchyma may protect implanted cells from destruction by alloimmune processes, thus enabling them to influence T-cell development for an extended period of time.
Our studies demonstrate that intrathymic transfer of allogeneic cells in conjunction with a single dose of ALS can promote long-term survival of subsequently transplanted islet allografts. This model provides a novel strategy for the induction of specific unresponsiveness in adult rats and may lead to the development of methods that permit long-term allograft survival without the need for prolonged, nonspecific immunosuppression of the host.
